Date: 2012-04-06
Type of information:
Product name: low molecular weight dextran sulfate
Compound: low molecular weight dextran sulfate
Therapeutic area:
Action mechanism: Low molecular weight dextran sulfate is thought to work by causing the release from the bone marrow into the blood of ‘cytokine stromal cell-derived factor 1’, a substance known to attract and guide stem cells, resulting in stem cells being mobilised from the bone marrow into the blood stream.
Company: TikoMed (Sweden)
Disease: mobilisation of progenitor cells prior to stem cell transplantation
Latest news:
Patents:
Submission of marketing authorization application USA :
Submission of marketing authorization application UE:
Withdrawal of marketing authorization application USA:
Withdrawal of marketing authorization application UE:
US authorization:
UE authorization:
Favourable opinion UE:
Favourable opinion USA:
Orphan status USA: 2011-07-26
Orphan status UE: 2011-08-05
Pediatric exclusivit _USA:
Pediatric exclusivity UE: OTC status: Other news:
